Your browser doesn't support javascript.
loading
Implementation of a stereotactic body radiotherapy program for unresectable pancreatic cancer in an integrated community academic radiation oncology satellite network.
Augustyn, Alexander; Reed, Valerie I; Ahmad, Neelofur; Bhutani, Manoop S; Bloom, Elizabeth S; Bowers, John R; Chronowski, Gregory M; Das, Prajnan; Holliday, Emma B; Delclos, Marc E; Huey, Ryan W; Koay, Eugene J; Lee, Sunyoung S; Nelson, Christopher L; Taniguchi, Cullen M; Koong, Albert C; Chun, Stephen G.
Afiliação
  • Augustyn A; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas, M.D. Anderson Cancer Center, Houston, TX, United States.
  • Reed VI; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas, M.D. Anderson Cancer Center, Houston, TX, United States.
  • Ahmad N; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas, M.D. Anderson Cancer Center, Houston, TX, United States.
  • Bhutani MS; Department of Gastroenterology, Hepatology and Nutrition, Division of Internal Medicine, The University of Texas, M.D. Anderson Cancer Center, Houston, TX, United States.
  • Bloom ES; Department of Gastroenterology, Hepatology and Nutrition, Division of Internal Medicine, The University of Texas, M.D. Anderson Cancer Center, Houston, TX, United States.
  • Bowers JR; Department of Radiation Oncology, M.D. Anderson Albuquerque, Albuquerque, NM, United States.
  • Chronowski GM; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas, M.D. Anderson Cancer Center, Houston, TX, United States.
  • Das P; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas, M.D. Anderson Cancer Center, Houston, TX, United States.
  • Holliday EB; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas, M.D. Anderson Cancer Center, Houston, TX, United States.
  • Delclos ME; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas, M.D. Anderson Cancer Center, Houston, TX, United States.
  • Huey RW; Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine, The University of Texas, M.D. Anderson Cancer Center, Houston, TX, United States.
  • Koay EJ; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas, M.D. Anderson Cancer Center, Houston, TX, United States.
  • Lee SS; Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine, The University of Texas, M.D. Anderson Cancer Center, Houston, TX, United States.
  • Nelson CL; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas, M.D. Anderson Cancer Center, Houston, TX, United States.
  • Taniguchi CM; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas, M.D. Anderson Cancer Center, Houston, TX, United States.
  • Koong AC; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas, M.D. Anderson Cancer Center, Houston, TX, United States.
  • Chun SG; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas, M.D. Anderson Cancer Center, Houston, TX, United States.
Clin Transl Radiat Oncol ; 27: 147-151, 2021 Mar.
Article em En | MEDLINE | ID: mdl-33665384

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Sysrev_observational_studies Idioma: En Revista: Clin Transl Radiat Oncol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Sysrev_observational_studies Idioma: En Revista: Clin Transl Radiat Oncol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos